1. Home
  2. ACRV vs INTG Comparison

ACRV vs INTG Comparison

Compare ACRV & INTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACRV
  • INTG
  • Stock Information
  • Founded
  • ACRV 2018
  • INTG 1965
  • Country
  • ACRV United States
  • INTG United States
  • Employees
  • ACRV N/A
  • INTG N/A
  • Industry
  • ACRV Medicinal Chemicals and Botanical Products
  • INTG Building operators
  • Sector
  • ACRV Health Care
  • INTG Real Estate
  • Exchange
  • ACRV Nasdaq
  • INTG Nasdaq
  • Market Cap
  • ACRV 47.8M
  • INTG 38.9M
  • IPO Year
  • ACRV 2022
  • INTG N/A
  • Fundamental
  • Price
  • ACRV $2.01
  • INTG $20.00
  • Analyst Decision
  • ACRV Buy
  • INTG
  • Analyst Count
  • ACRV 6
  • INTG 0
  • Target Price
  • ACRV $17.75
  • INTG N/A
  • AVG Volume (30 Days)
  • ACRV 556.9K
  • INTG 3.2K
  • Earning Date
  • ACRV 11-12-2025
  • INTG 11-12-2025
  • Dividend Yield
  • ACRV N/A
  • INTG N/A
  • EPS Growth
  • ACRV N/A
  • INTG N/A
  • EPS
  • ACRV N/A
  • INTG N/A
  • Revenue
  • ACRV N/A
  • INTG $64,378,000.00
  • Revenue This Year
  • ACRV N/A
  • INTG N/A
  • Revenue Next Year
  • ACRV $805.34
  • INTG N/A
  • P/E Ratio
  • ACRV N/A
  • INTG N/A
  • Revenue Growth
  • ACRV N/A
  • INTG 10.73
  • 52 Week Low
  • ACRV $1.05
  • INTG $9.57
  • 52 Week High
  • ACRV $8.74
  • INTG $20.87
  • Technical
  • Relative Strength Index (RSI)
  • ACRV 69.57
  • INTG 61.60
  • Support Level
  • ACRV $1.82
  • INTG $18.84
  • Resistance Level
  • ACRV $2.00
  • INTG $20.66
  • Average True Range (ATR)
  • ACRV 0.12
  • INTG 1.03
  • MACD
  • ACRV 0.01
  • INTG -0.10
  • Stochastic Oscillator
  • ACRV 87.68
  • INTG 82.47

About ACRV Acrivon Therapeutics Inc.

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.

About INTG Intergroup Corporation (The)

The Intergroup Corp is an us-based company operating in the real estate sector. It is formed to buy, develop, operate, rehabilitate and dispose of real property of various types and descriptions, and to engage in other related business and investment activities. The company operates through three segments namely Hotel Operations, Real Estate Operations, and Investment Transactions. The Hotel Operations segment which generates the majority of the revenue covers the operation of the Hilton hotel and garage. The Real Estate Operations segment consists of the operation of multifamily rental properties whereas the Investment Transactions segment includes an investment of cash in marketable securities and other investments.

Share on Social Networks: